“Curing All Disease by next century is too conservative" - Mark Zuckerberg

No Priors: AI, Machine Learning, Tech, & Startups

Summary

Mark Zuckerberg, Priscilla Chan, and Alex Reeves discuss the evolution of the Chan Zuckerberg Initiative's Biohub into a frontier AI-biology lab. The conversation details their mission to accelerate scientific progress by creating open-source tools, ranging from protein folding models to cell atlases, that help the scientific community understand and treat disease at an individual, mechanistic level. By integrating wet-lab experiments with AI world models, they aim to transition biology from a discovery-based science to a predictable engineering-based discipline.

Chapters

  1. 0:00Introduction to Biohub mission
  2. 2:06Biohub structure and strategy
  3. 10:23Single cell data and Cellxgene
  4. 15:47AI in frontier biology
  5. 28:15Impact of venture backed science
  6. 37:00Understanding genetics and disease
  7. 47:00Atomic resolution and protein modeling
  8. 55:00Future outlook and team building

Topics covered

  • Scientific Tool Development
  • AI-Driven Biological Models

+4 more topics (full content when you follow the channel)

Transcript excerpt

We just want to give tools to the whole scientific community. >> We want to understand how biology works. I want to understand the genetics of this person. I want to understand the risks they have to different illnesses. My goal is to be able to treat the individual as an individual, understand the mechanisms and [music] be able to intervene. >> We'll have a bigger impact by getting this in more scientist hands quicker by doing it as open source projects instead. It's not just like there's some factory somewhere that you can pay to [music] produce the data. You actually need to invent new novel scientific approaches. The theory isn't that we're going to cure the diseases. We're not. It's that we want to help accelerate the pace of progress for the whole scientific field. We folded over 1.1 [music] billion proteins and predicted their structures. And we didn't design a model for antibodie…